Prot #LP0133-1275: Phase 2b Dose-Ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-Week Treatment Period in Adult Subjects with Atopic Dermatitis

Project: Research project

Project Details

StatusActive
Effective start/end date7/11/19 → 7/11/23

Funding

  • Covance Inc. (Prot #LP0133-1275)
  • LEO Pharma A/S (Prot #LP0133-1275)
View all
View less